NCT05747950

Brief Summary

The aim of our study is to objectively and clearly determine the differences between the Spasticity and Decreased Functionality in the Upper Extremity Flexor Group Muscles After Stroke, the Vibration, mBZHT and Physiotherapy and Rehabilitation Applications in terms of treatment process and effectiveness, and to increase the use of the hands and upper extremities in the daily life activities of the patient.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
45

participants targeted

Target at P50-P75 for not_applicable stroke

Timeline
Completed

Started Jan 2023

Shorter than P25 for not_applicable stroke

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 8, 2023

Completed
2 days until next milestone

Study Start

First participant enrolled

January 10, 2023

Completed
2 months until next milestone

First Posted

Study publicly available on registry

February 28, 2023

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 25, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 25, 2023

Completed
Last Updated

October 18, 2023

Status Verified

October 1, 2023

Enrollment Period

6 months

First QC Date

January 8, 2023

Last Update Submit

October 17, 2023

Conditions

Outcome Measures

Primary Outcomes (2)

  • Modified Ashworth Scale (MAS)

    It is the most widely used clinical scale to evaluate spasticity. Despite its widespread clinical use, the reliability of the scale is questioned in some studies. Recent publications indicate that more studies are needed on the reliability of the scale.

    Change in Upper Extremity Spasticity at 8 Weeks,Two measurements before and after treatment, 1 minute

  • Modified Tardieu Scale (MTS)

    Like the MAS, the Modified Tardieu Scale (MTS) is another clinical scale used to assess spasticity. Although it is not as widely used as MAS, it is recommended as a more effective method in the evaluation of spasticity because it measures resistance to passive movement at two different rates. While performing MTS, the extremities are moved passively with V1, V2 and V3 velocities. V1 speed; as slow as possible (slower than the gravity fall velocity of the limb segment), V2 velocity is defined as the extremity fall velocity, and V3 velocity is defined as as fast as possible (faster than the normal gravity fall velocity of the limb). In MTS, V1 velocity can be used to measure passive range of motion, and V2 or V3 velocities can be used to measure spasticity.

    Change in Upper Extremity Spasticity at 8 Weeks,Two measurements before and after treatment, 1 minute

Secondary Outcomes (5)

  • Fugl-Meyer Upper Extremity Rating Scale

    Change in Upper Extremity Functionality at 8 Weeks,Two measurements before and after treatment, 5 minutes

  • Nine Hole Peg Test

    Change in Upper Extremity Functionality at 8 Weeks,Two measurements before and after treatment, 4 minutes

  • Stroke-Specific Quality of Life Scale

    Change in Upper Extremity Functionality at 8 Weeks,Two measurements before and after treatment, 5 minutes

  • Box and Block Test (BBT)

    Change in Upper Extremity Functionality at 8 Weeks,Two measurements before and after treatment, 1 minute

  • Upper Extremity Motor Activity Diary-28

    Change in Upper Extremity Functionality at 8 Weeks,Two measurements before and after treatment, 5 minutes

Study Arms (3)

Vibration group

OTHER

Vibration is defined as "a mechanical stimulus characterized by oscillating movements". has been defined.The first method is a hand held as a local vibration application that can be applied directly to the widest part of the muscle with the object.is named. The second method, called whole body vibration, is a vibration source applied on the platform. Participants immediately after the sessions in addition to conventional physiotherapy. Upper extremity flexor on the hemiplegic side in supine position, 8 weeks, 3 sessions per week with a CE certified vibration device with a frequency of 50-110 Hz and an amplitude of 1-4 mm. Local vibration will be applied for 15 minutes each.

Other: Vibration

Modified Constraint-Induced Movement Therapy group

OTHER

Modified Constraint-İnduced Movement Therapy is a rehabilitation technique that promotes 'repetitive' use of the affected upper extremity in people with upper extremity neurological motor deficits. Constraint-İnduced Movement Therapy upper extremity after stroke it is a rehabilitation approach used to increase functional use. post stroke Approximately 20-25% of surviving patients can meet the motor criteria of mCIMT. Participants In addition to conventional treatment, they can use their intact extremities at home with a shoulder stabilization orthosis.Restraint, grasping on the hemiplegic side, using spoons and forks, combing hair daily life activities, 8 weeks, 3 days a week, and approximately 3 hours Modified Constraint-İnduced Movement Therapy m(CIMT) will be applied.

Other: Modified Constraint-İnduced Movement Therapy

Control group

OTHER

Control group in the training group, will be given a program that includes joint range of motion exercises, strengthening exercises, mobility and transfer activities, and various activities in order to increase participation in daily life activities as a routine conventional treatment in 60-minute sessions, 3 days a week, for 8 weeks.

Other: Conventional Therapy

Interventions

Vibration is used as an alternative to physical exercise in various areas to increase muscle performance and flexibility, improve balance and proprioception, reduce spasticity and increase bone density.

Vibration group

Compulsory use therapy is a form of treatment in which the movements of the healthy side are prevented and the use of the weak side is encouraged in the stroke patient.

Modified Constraint-Induced Movement Therapy group

Conventional exercises

Control group

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Those who are diagnosed with stroke between the ages of 18-75 and can stand
  • No cognitive and communication problems
  • Persons weighing less than 150 kg
  • Patients who have had at least 10 days after Botox application

You may not qualify if:

  • Individuals who are not stable in terms of vital signs
  • Those who have any open wounds on their upper extremities
  • Those with spasticity and contracture that prevent sole contact
  • Pathological conditions affecting upper extremity sensation (after surgery after fracture etc.)
  • Those with a Mini Mental Test score below 24
  • Posterior circulation stroke (stroke type in which basilar artery and cerebellum are affected)
  • Arterial blood circulation disorders
  • Lymphatic Edema
  • Those who have been diagnosed with Multiple Sclerosis, Parkinson's and other neurological diseases
  • People with vision and hearing problemsPatients who have been diagnosed with stroke for at least 8 weeks

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kırıkkale University Faculty of Health Sciences Department of Physiotherapy and Rehabilitation

Kırıkkale, Merkez, 71000, Turkey (Türkiye)

Location

Related Publications (3)

  • Nasb M, Li Z, S A Youssef A, Dayoub L, Chen H. Comparison of the effects of modified constraint-induced movement therapy and intensive conventional therapy with a botulinum-a toxin injection on upper limb motor function recovery in patients with stroke. Libyan J Med. 2019 Dec;14(1):1609304. doi: 10.1080/19932820.2019.1609304.

    PMID: 31032717BACKGROUND
  • Caliandro P, Celletti C, Padua L, Minciotti I, Russo G, Granata G, La Torre G, Granieri E, Camerota F. Focal muscle vibration in the treatment of upper limb spasticity: a pilot randomized controlled trial in patients with chronic stroke. Arch Phys Med Rehabil. 2012 Sep;93(9):1656-61. doi: 10.1016/j.apmr.2012.04.002. Epub 2012 Apr 13.

  • Hsieh HC, Liao RD, Yang TH, Leong CP, Tso HH, Wu JY, Huang YC. The clinical effect of Kinesio taping and modified constraint-induced movement therapy on upper extremity function and spasticity in patients with stroke: a randomized controlled pilot study. Eur J Phys Rehabil Med. 2021 Aug;57(4):511-519. doi: 10.23736/S1973-9087.21.06542-4. Epub 2021 Jan 15.

MeSH Terms

Conditions

StrokeMobility Limitation

Interventions

Vibration

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Mechanical PhenomenaPhysical Phenomena

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Masking Details
Researcher: Kırıkkale University, Institute of Health Sciences, 2nd year graduate student with thesis, physiotherapist, Zuhal Şevval Gökdere Participants: In this study, Kırıkkale University Faculty of Medicine, Physical Therapy and Physical Therapy in Rehabilitation Hospital and Tokat State Hospital Volunteer treated in the unit, between 18-75 years old, diagnosed with stroke, 45 individual will be included.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: In the study, 45 individuals between the ages of 18-75 who were diagnosed with stroke and met the inclusion criteria will be recruited. Individuals will be divided into 3 groups according to different treatment methods.
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
physiotherapist

Study Record Dates

First Submitted

January 8, 2023

First Posted

February 28, 2023

Study Start

January 10, 2023

Primary Completion

June 25, 2023

Study Completion

June 25, 2023

Last Updated

October 18, 2023

Record last verified: 2023-10

Data Sharing

IPD Sharing
Will share

Working Protocol with Other Researchers, Statistical Analysis Plan (SAP),Informed Consent Form (ICF),Clinical Trial Report (CSR) and Analytical Code will be shared.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
Time Frame
January 10, 2023 - June 10, 2023

Locations